{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:19:39Z","timestamp":1790378379043,"version":"4.1.0"},"reference-count":49,"publisher":"BMJ","issue":"11","funder":[{"name":"Director Kurt B\u00f8nnelycke and Mrs. Grethe B\u00f8nnelycke Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Research Foundation for Health Research of the Capital Region of Denmark","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Adiponectin, an adipocyte-secreted protein-hormone with inflammatory properties, has a potentially important role in the development and progression of asthma. Unravelling whether adiponectin is a causal risk factor for asthma is an important issue to clarify as adiponectin could be a potential novel drug target for the treatment of asthma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We tested the hypothesis that plasma adiponectin is associated observationally and causally (using genetic variants as instrumental variables) with risk of asthma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In the Copenhagen General Population Study, we did an observational analysis in 28 845 individuals (2278 asthma cases) with plasma adiponectin measurements, and a genetic one-sample Mendelian randomisation analysis in 94 868 individuals (7128 asthma cases) with 4 genetic variants. Furthermore, in the UK Biobank, we did a genetic two-sample Mendelian randomisation analysis in 462 933 individuals (53 598 asthma cases) with 12 genetic variants. Lastly, we meta-analysed the genetic findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>While a 1 unit log-transformed higher plasma adiponectin in the Copenhagen General Population Study was associated with an observational OR of 1.65 (95% CI 1.29 to 2.08) for asthma, the corresponding genetic causal OR was 1.03 (95% CI 0.75 to 1.42). The genetic causal OR for asthma in the UK Biobank was 1.00 (95% CI 0.99 to 1.00). Lastly, genetic meta-analysis confirmed lack of association between genetically high plasma adiponectin and causal OR for asthma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Observationally, high plasma adiponectin is associated with increased risk of asthma; however, genetic evidence could not support a causal association between plasma adiponectin and asthma.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2021-217675","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T18:28:43Z","timestamp":1640284123000},"page":"1070-1077","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Plasma adiponectin and risk of asthma: observational analysis, genetic Mendelian randomisation and meta-analysis"],"prefix":"10.1136","volume":"77","author":[{"given":"Maria Booth","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-829X","authenticated-orcid":false,"given":"Yunus","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"2023100203000914000_77.11.1070.1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.26746"},{"key":"2023100203000914000_77.11.1070.2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1557"},{"key":"2023100203000914000_77.11.1070.3","doi-asserted-by":"publisher","DOI":"10.2174\/092986712803833263"},{"key":"2023100203000914000_77.11.1070.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61536-6"},{"key":"2023100203000914000_77.11.1070.5","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjw012"},{"key":"2023100203000914000_77.11.1070.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2017.01.004"},{"key":"2023100203000914000_77.11.1070.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.04.021"},{"key":"2023100203000914000_77.11.1070.8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.090803"},{"key":"2023100203000914000_77.11.1070.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201110-1767OC"},{"key":"2023100203000914000_77.11.1070.10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.EJ12-0277","article-title":"Low-Molecular-weight adiponectin is more closely associated with episodes of asthma than high-molecular-weight adiponectin","volume":"60","author":"Matsumoto","year":"2013","journal-title":"Endocr J"},{"key":"2023100203000914000_77.11.1070.11","doi-asserted-by":"publisher","DOI":"10.1080\/02770900802444203"},{"key":"2023100203000914000_77.11.1070.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01872.x"},{"key":"2023100203000914000_77.11.1070.13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)60161-5","article-title":"Leptin, adiponectin, and asthma: findings from a population-based cohort study","volume":"103","author":"Sutherland","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2023100203000914000_77.11.1070.14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2011.00055","article-title":"Serum adiponectin is associated with adverse outcomes of asthma in men but not in women","volume":"2","author":"Sood","year":"2011","journal-title":"Front Pharmacol"},{"key":"2023100203000914000_77.11.1070.15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/1389203716666150120095342","article-title":"Adiponectin in asthma: implications for phenotyping","volume":"16","author":"Nigro","year":"2015","journal-title":"Curr Protein Pept Sci"},{"key":"2023100203000914000_77.11.1070.16","first-page":"1192","article-title":"From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment","volume":"114","author":"Benn","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2023100203000914000_77.11.1070.17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10654-021-00726-8","article-title":"Are mendelian randomization investigations immune from bias due to reverse causation?","volume":"36","author":"Burgess","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"2023100203000914000_77.11.1070.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000768"},{"key":"2023100203000914000_77.11.1070.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.11.035"},{"key":"2023100203000914000_77.11.1070.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002607"},{"key":"2023100203000914000_77.11.1070.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3034"},{"key":"2023100203000914000_77.11.1070.22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"2023100203000914000_77.11.1070.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779"},{"key":"2023100203000914000_77.11.1070.24","unstructured":"Neale Lab , 2018. Available: http:\/\/www.nealelab.is\/uk-biobank\/"},{"key":"2023100203000914000_77.11.1070.25","doi-asserted-by":"crossref","unstructured":"Elsworth B , Lyon M , Alexander T . The MRC IEU OpenGWAS data infrastructure. bioRxiv 2020;244293.doi:10.1101\/2020.08.10.244293","DOI":"10.1101\/2020.08.10.244293"},{"key":"2023100203000914000_77.11.1070.26","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215288"},{"key":"2023100203000914000_77.11.1070.27","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/clinchem\/hvaa227","article-title":"Causal relationship between plasma adiponectin and body mass index: one- and two-sample bidirectional mendelian randomization analyses in 460 397 individuals","volume":"66","author":"Nielsen","year":"2020","journal-title":"Clin Chem"},{"key":"2023100203000914000_77.11.1070.28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv402"},{"key":"2023100203000914000_77.11.1070.29","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207379"},{"key":"2023100203000914000_77.11.1070.30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10654-018-0393-9","article-title":"Low concentrations of 25-hydroxyvitamin D and long-term prognosis of COPD: a prospective cohort study","volume":"33","author":"F\u00e6rk","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"2023100203000914000_77.11.1070.31","doi-asserted-by":"crossref","unstructured":"Harrell FE . Regression modelling strategies: with applications to linear models, logistic regression, and survival analysis. 1st edn. New York: Springer, 2001.","DOI":"10.1007\/978-1-4757-3462-1_1"},{"key":"2023100203000914000_77.11.1070.32","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4197"},{"key":"2023100203000914000_77.11.1070.33","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr026"},{"key":"2023100203000914000_77.11.1070.34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gepi.22295","article-title":"A comparison of robust Mendelian randomization methods using summary data","volume":"44","author":"Slob","year":"2020","journal-title":"Genet Epidemiol"},{"key":"2023100203000914000_77.11.1070.35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ije\/dyy195","article-title":"Software application profile: mrrobust\u2014a tool for performing two-sample summary Mendelian randomization analyses","volume":"48","author":"Spiller","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2023100203000914000_77.11.1070.36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"2023100203000914000_77.11.1070.37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2023100203000914000_77.11.1070.38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238990","article-title":"Lung regulatory T cells express adiponectin receptor 1: modulation by obesity and airway allergic inflammation","volume":"21","author":"Ramos-Ram\u00edrez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023100203000914000_77.11.1070.39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.684"},{"key":"2023100203000914000_77.11.1070.40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0573OC"},{"key":"2023100203000914000_77.11.1070.41","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213678"},{"key":"2023100203000914000_77.11.1070.42","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214164"},{"key":"2023100203000914000_77.11.1070.43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/785835","article-title":"Adiponectin, leptin, and resistin in asthma: basic mechanisms through population studies","volume":"2013","author":"Sood","year":"2013","journal-title":"J Allergy"},{"key":"2023100203000914000_77.11.1070.44","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2016-000127"},{"key":"2023100203000914000_77.11.1070.45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222362"},{"key":"2023100203000914000_77.11.1070.46","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ije\/dyaa266","article-title":"Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations","volume":"50","author":"Hartwig","year":"2021","journal-title":"Int J Epidemiol"},{"key":"2023100203000914000_77.11.1070.47","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00558-2020","article-title":"Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population","volume":"56","author":"\u00c7olak","year":"2020","journal-title":"Eur Respir J"},{"key":"2023100203000914000_77.11.1070.48","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.5.406"},{"key":"2023100203000914000_77.11.1070.49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2021-217675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T10:01:58Z","timestamp":1696240918000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2021-217675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,10,14]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/thoraxjnl-2021-217675"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217675","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]}}}